SCHEMBL25840781

SCHEMBL25840781

Cc1ccc(NC(=S)NCCCS(=O)(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.56
QPCT Q16769 1/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
LMNA P02545 4/20 0.50
HPGD P15428 3/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
HTT P42858 4/20 0.49
MAPT P10636 3/20 0.49
ALDH1A1 P00352 2/20 0.49
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
DUSP3 P51452 1/20 0.48
PTPN5 P54829 1/20 0.48
PTPN11 Q06124 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
ALOX12 P18054 1/20 0.48
CA12 O43570 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25840779 0.92 SMN1; SMN2 (0.54) RECQLQPCTSMN1; SMN2LMNAHPGD
SCHEMBL29043442 0.88 RECQL (0.53) RECQLQPCTSMN1; SMN2LMNAHPGD
SCHEMBL25840780 0.85 ALDH1A1 (0.59) SMN1; SMN2HTTALDH1A1CA1CA2
SCHEMBL25840772 0.84 SMN1; SMN2 (0.58) SMN1; SMN2LMNAHPGDMEN1KMT2A
SCHEMBL17982696 0.81 LMNA (0.65) RECQLQPCTSMN1; SMN2LMNAHPGD
SCHEMBL23328393 0.81 SMN1; SMN2 (0.68) SMN1; SMN2LMNAHPGDMEN1KMT2A
SCHEMBL23328405 0.80 SMN1; SMN2 (0.67) SMN1; SMN2LMNAHPGDMEN1KMT2A
SCHEMBL27941612 0.80 RECQL (0.54) RECQLQPCTSMN1; SMN2LMNAMEN1
SCHEMBL9852004 0.79 MAPT (0.55) LMNAMEN1KMT2AMAPTALDH1A1
SCHEMBL17972729 0.79 SMN1; SMN2 (0.65) RECQLQPCTSMN1; SMN2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701333-B2 Antibacterial compounds ARF1, ARL1, TLR1 RECQL 2422/4885QPCT 2942/4885SMN1; SMN2 3087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.